The challenges in assessing contrast-induced nephropathy: Where are we now?

American Journal of Roentgenology

Volumn 202, Issue 4, 2014, Pages 784-789

  Davenport, Matthew S ^a   Cohan, Richard H ^a   Khalatbari, Shokoufeh ^b   Ellis, James H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Complications; Contrast media; Contrast induced nephropathy (CIN); Low osmolar contrast medium (LOCM); Safety

Indexed keywords

CREATININE; IODINATED CONTRAST MEDIUM;

ANGIOCARDIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CONTROL GROUP; CREATININE BLOOD LEVEL; EVIDENCE BASED MEDICINE; HUMAN; PRIORITY JOURNAL; PROPENSITY SCORE; RARE DISEASE; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SELECTION BIAS;

CONTRAST MEDIA; DATA INTERPRETATION, STATISTICAL; DIAGNOSTIC IMAGING; HUMANS; IODINE; KIDNEY DISEASES; OSMOLAR CONCENTRATION; PATIENT SAFETY; RISK FACTORS;

EID: 84897008956     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.11369     Document Type: Review

References (50)

1. Heneghan M. Contrast-induced acute renal failure. AJR 1978; 131:1113-1115
2. Weinrauch LA, Robertson WS, D'Elia JA. Contrast-media induced acute renal failure. JAMA 1978; 239:2018-2019
3. Lund G, Einzig S, Rysavy J, et al. Role of ischemia in contrast-induced renal damage: an experimental study. Circulation 1984; 69:783-789 (Pubitemid 14125660)
4. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 1989; 320:143-149 (Pubitemid 19033091)
5. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39:930-936 (Pubitemid 34454211)
6. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 2006; 113:1799-1806 (Pubitemid 43958473)
7. Rao QA, Newhouse JH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 2006; 239:392-397
8. Valette X, Parienti JJ, Plaud B, et al. Incidence, morbidity, and mortality of contrast-induced acute kidney injury in a surgical intensive care unit: a prospective cohort study. J Crit Care 2012; 27:322.e1-322.e5
9. Nyman U, Almén T, Jacobsson B, et al. Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections? Eur Radiol 2012; 22:1366-1371
10. Katzberg RW, Morris TW, Schulman G, et al. Reactions to intravenous contrast media. Part II. Acute renal response in euvolemic and dehydrated dogs. Radiology 1983; 147:331-334 (Pubitemid 13133197)
11. Katzberg RW, Barrett BJ. Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology 2007; 243:622-628 (Pubitemid 46799414)
12. Katzberg RW, Newhouse JH. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology 2010; 256:21-28
13. Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR 2008; 191:376-382
14. McDonald JS, McDonald RJ, Comin J, et al. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology 2013; 267:119-128
15. American College of Radiology Committee on Drugs and Contrast Media. Manual on contrast media, 9th ed. Reston, VA: American College of Radiology, 2013
16. Parikh CR, Devarajan P. New biomarkers of acute kidney injury. Crit Care Med 2008; 36(suppl 4):S159-S165 (Pubitemid 351483046)
17. Baumgarten DA, Ellis JH. Contrast-induced nephropathy: contrast material not required? AJR 2008; 191:383-386
18. Stratta P, Izzo C, Canavese C, Quaglia M. Letter to the editor re: are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections? (letter) Eur Radiol 2013; 23:1260-1263
19. Gruskin AB, Oetliker OH, Wolfish NM, Gootman NL, Bernstein J, Edelmann CM Jr. Effects of angiography on renal function and histology in infants and piglets. J Pediatr 1970; 76:41-48
20. Tadavarthy SM, Castaneda W, Amplatz K. Redistribution of renal blood flow caused by contrast media. Radiology 1977; 122:343-348 (Pubitemid 8028946)
21. Jensen H, Doughty RW, Grant D, et al. A modified model of gentamicin induced renal failure in rats: toxicological effects of the iodinated X-ray contrast media ioversol and potential usefulness for toxicological evaluation of iodinated X-ray contrast media. Exp Toxicol Pathol 2013; 65:601-607
22. Porter GA, Kloster FE, Bristow JD. Sequential effect of angiographic contrast agent on canine renal and systemic hemodynamics. Am Heart J 1971; 81:80-92
23. Ziegler TW, Ludens JH, Fanestil DD, et al. Inhibition of active sodium transport by radiographic contrast media. Kidney Int 1975; 7:68-76
24. Deray G, Dubois M, Martinez F, et al. Renal effects of radiocontrast agents in rats: a new model of acute renal failure. Am J Nephrol 1990; 10:507-513
25. Liu ZZ, Viegas VU, Perlewitz A, et al. Iodinated contrast media differentially affect afferent and efferent arteriolar tone and reactivity in mice: a possible explanation for reduced glomerular filtration rate. Radiology 2012; 265:762-771
26. Sendeski M, Patzak A, Pallone TL, et al. Iodixanol, constriction of medullary descending vasa recta, and risk of contrast-medium-induced nephropathy. Radiology 2009; 251:697-704
27. Heinrich MC, Kuhlmann MK, Grgic A, Heckmann M, Kramann B, Uder M. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology 2005; 235:843-849 (Pubitemid 40695879)
28. Aulicky P, Mikulik R, Goldemund D, et al. Safety of performing CT angiography in stroke patients treated with intravenous thrombolysis. J Neurol Neurosurg Psychiatry 2010; 81:783-787
29. Bansal GJ, Darby M. Measurement of change in estimated glomerular filtration rate in patients with renal insufficiency after contrast-enhanced computed tomography: a case-control study. J Comput Assist Tomogr 2009; 33:455-459
30. Bruce RJ, Djamali A, Shinki K, Michel SJ, Fine JP, Pozniak MA. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR 2009; 192:711-718
31. Cramer BC, Parfrey PS, Hutchinson TA, et al. Renal function following infusion of radiologic contrast material: a prospective controlled study. Arch Intern Med 1985; 145:87-89 (Pubitemid 15233123)
32. Heller CA, Knapp J, Halliday J, et al. Failure to demonstrate contrast nephrotoxicity. Med J Aust 1991; 155:329-332
33. Langner S, Stumpe S, Kirsch M, et al. No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium. AJNR 2008; 29:1525-1529
34. Lima FO, Lev MH, Levy RA, et al. Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy. AJNR 2010; 31:817-821
35. McGillicuddy EA, Schuster KM, Kaplan LJ, et al. Contrast-induced nephropathy in elderly trauma patients. J Trauma 2010; 68:294-297
36. Ng CS, Shaw AD, Bell CS, Samuels JA. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU. AJR 2010; 195:414-422
37. Oleinik A, Romero JM, Schwab K, et al. CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke 2009; 40:2393-2397
38. Tremblay LN, Tien H, Hamilton P, et al. Risk and benefit of intravenous contrast in trauma patients with an elevated serum creatinine. J Trauma 2005; 59:1162-1166
39. Parsons LS. Performing a 1: N case-control match on propensity score. Proceedings of the 29th Annual SAS users group international conference. Cary, NC: SAS Institute, 2004
40. Davenport MS, Khalatbari S, Dillman RJ, et al. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 2013; 267:94-105
41. McDonald RJ, McDonald JS, Bida JP, et al. Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 2013; 267:106-118
42. Davenport MS, Khalatbari S, Cohan RH, Dillman JR, Myles JD, Ellis JH. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology 2013; 268:719-728
43. Davenport MS, Khalatbari S, Cohan RH, Ellis JH. Contrast medium-induced nephrotoxicity risk assessment in adult inpatients: a comparison of serum creatinine level- and estimated glomerular filtration rate-based screening methods. Radiology 2013; 269:92-100
44. Ellis JH, Cohan RH. Reducing the risk of contrast-induced nephropathy: a perspective on the controversies. AJR 2009; 192:1544-1549
45. Mehta RL, Kellum JA, Shah SV, et al.; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31
46. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative Workgroup. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs - the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212
47. Waikar SS, Betensky RA, Bonventre JV. Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant 2009; 24:3263-3265
48. Dennen P, Parikh CR. Biomarkers of acute kidney injury: can we replace serum creatinine? Clin Nephrol 2007; 68:269-278 (Pubitemid 350047759)
49. Valette X, du Cheyron D. A critical appraisal of the accuracy of the RIFLE and AKIN classifications in defining "acute kidney insufficiency" in critically ill patients. J Crit Care 2013; 28:116-125
50. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16:3365-3370 (Pubitemid 46179340)